Clinical Evaluation Of Nishakathakadi Ghanvati As An Adjuvant Therapy In The Management Of Jataja Prameha (Juvenile Diabetes)

CLINICAL EVALUATION OF NISHAKATHAKADI GHANVATI AS AN ADJUVANT THERAPY IN THE MANAGEMENT OF JATAJA PRAMEHA (JUVENILE DIABETES)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054655

Enrollment

Registered

2023-07-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E109- Type 1 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group 6 years to 16 years age of either sex. 2. Pre-diagnosed cases of T1DM (Juvenile diabetes) 3. Patients having FBS =126mg/dl, PPBS =200 mg/dl, HbA1c =6.5%

Exclusion criteria

Exclusion criteria: 1. Children below 6 years and above 16 years. 2. Children with tendency to have recurrent DKA (Diabetic Keto Acidosis). 3. Children with complication of disease like diabetic foot etc. 4. Children with other infectious disease such as TB etc, other metabolic disease, other endocrinal disease, genetic anomalies etc.

Design outcomes

Primary

Measure	Time frame
•Reduction in dose of insulin per day. •Changes in laboratory investigations like HBA1C, FBS, PPBS. Timepoint: 3 months	—

Secondary

Measure	Time frame
• Relief in sign & symptoms of Jataja prameha. • Improvement in QOL of children with Juvenile diabetes. Timepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Nisha Kumari Ojha

National Institute of Ayurveda jaipur

drnishaojha@gmail.com9468650449

Outcome results